HOW SYSTEMIC ENZYMES WORK TO CURE DISEASES PART 1 of 2

[Guest guest]

Normal 0 false false false

MicrosoftInternetExplorer4 HOWSYSTEMIC ENZYMES WORK TO CURE DISEASES

PART 1 of 2

http://www.newswithviews.com/Howenstine/james174.htm

 

By Dr. Howenstine, MD.

March 17, 2009

NewsWithViews.com

 

Aging appears to begin between the ages of 27 and 35 whenthe production of

enzymes that dissolve protein begins to diminish. Enzymes arewidely recognized

for their importance in digesting food. They also break upcirculating immune

complexes in the blood. Enzymes can act to prevent too muchfibrin from being

deposited in wounds, fractures and joints. These enzymes alsoremove necrotic

debris and excess fibrin from the blood stream. Immune systemregulation can also

be accomplished with enzymes. Most of the development ofsystemic enzyme therapy

was carried out in the Far East and Europe.Enzyme therapy is a prime example of

a situation in which US medicine ismissing the boat due to a lack o of awareness

of what the rest of the world isdoing and our unwillingness to use therapies not

made by “big pharma.†Enzymescan not be patented so they are of little

interest to drug companies.

 

The proteolytic enzymes used in enzyme therapy dissolvefibrin. When strong

proteolytic enzymes are in an enzymepreparation, they can be powerful enough in

their action to actually graduallydigest scar tissue away. This takes time to

occur, of course, but eventuallyall the scar tissue may disappear.

 

Sometimes when the body deposits excess fibrin in a tissuethe tendon sheaths

become thickened and the free movement of a tendon back andforth fails to occur

with the tendon getting caught in the fibrous tissue (e.g.trigger finger,

Dupytron’s contracture of the palm, etc.) and failure of normalfunction

occurs. Tissues containing excess fibrin are weak because they do notprovide

adequate space for the epithelial tissue that normally grows throughthe whole

fibrin matrix, producing strength.

 

These tissues with excess fibrin have restricted motion ifjoints are involved

and will have diminished size and function if the scarringinvolves an internal

organ(e.g. heart after infarction, kidney after a clot toa kidney artery,

pancreas after episode of pancreatitis, etc.)

 

Systemic enzymes have a unique feature. Sideeffects do not occur with systemic

enzymes. This means that raisingthe dosage to massive levels does not cause any

problems unlike pharmaceutical drugs.The initial dosage, which is often one

potent enzyme pill three daily taken 45minutes before or 45 minutes after a

meal, can be raised by three tablets dailyevery few days until the desired

therapeutic response develops.. A person givenmore than 3700 enzyme tablets in

one day experienced only diarrhea from thismassive capsule intake.

 

A second interesting facet of systemic enzymes is that theireffects on

coagulation intensify the actions of blood thinning drugs like coumadin.Fibrin

digests with enzymes which dissolves blood clots .Persons onanti-coagulant drugs

and individuals with hemophilia may have more intensebleeding with enzyme

therapy, and should avoid using enzymes.

 

Use of Vitalzym inDisease Conditions

 

Vitalzyme + is an enzyme formulation that contains protease,serrapeptase,

papain, bromelain, amylase, lipase, rutin and amia, which is arich source of

vitamin C. Serrapeptase is a unique proteolytic enzyme isolatedfrom

non-pathogenic enterobacteria Serratia E 15 that has superioranti-inflammatory

action[1]when compared to other proteolytic enzymes. Serrapeptase is the enzyme

found inthe intestine of the silkworm that permits the silkworm to break out of

thecocoon.

 

In addition to breaking down fibrin deposits,Vitalzyme+ reduces inflammation,

removes and filters viruses from the blood,balances the immune system, and

removes toxins from the blood. Thesystemic effects of enzymes can be used to

prevent and resolve many diseases.The rutin contained in Vitalzym has valuable

properties. Rutin is abioflavinoid which composes 4-6% of buckwheat. Rutin

strengthens and controlsthe permeability of blood vessels and capillary walls.

This turns weak bloodvessels into strong ones that are less likely to bleed.

Rutin lowers the bloodpressure and slows aging.

Bioflavinoids, such as rutin, quercitin, and hesperidin, are

powerfulantioxidants that effectively combat free radicals believed to cause 90%

ofdiseases(cancer, arteriosclerosus, arthritis, aging etc.) Other

enzymeformulations such as Nattokinase, Lumbrokinase, and Wobenzym contain

potentenzymes such as chymotrypsin which make them very effective.

 

Many articles have been written recently extolling thevirtues of serrapeptase.

Serrapeptasehas anti-inflammatory, anti-edema, and fibrinolytic properties. A

study inotolaryngological patients from many centers in Italy disclosed that

serrapeptasewas very effective in alleviating thick infected

secretions.[2]Ninety one percent of those taking serrapeptase reported good to

excellentresults compared to 22% in the control subjects. Knee cartilage

operations werefollowed by 50% less swelling[2]in the group of patients taking

serrapeptase. Patients with fibrocystic breastpain[3]reported 85% marked to

moderate improvement compared to 65% not receivingserrapeptase. Twenty patients

(average age 39) with carpal tunnel syndrome[4]were given 10 mg of serrapeptase

twice daily. Thirteen of these were betterwith electrophysiologic proof of

recovery.

 

Enzyme Therapy InMalignancies

 

In Europe, therapy ofmalignancies usually includes enzymes in large dosage which

has lengthenedsurvival. Enzyme preparations are carefully formulated so they are

able toavoid dissolving in stomach acid and thus are available to get into the

bloodwithout being destroyed.

In cancer cases, the cancer cells are surrounded by a layerof fibrin which may

be up to 15 times thicker than the layer of fibrin thatsurrounds normal cells.

This fibrin layer permits these malignant cells toescape destruction by killer

immune cells, which are unable to detect thecancer cell antigens. The systemic

enzymes are able to remove this fibrincoating, permitting the immune cells to

again kill the tumor cells.Additionally, immune cells become stimulated by

enzymes to increase theproduction of tumor necrosis factor which can attack

tumor cells, as well ascells infected by viruses. This is vital to cancer

defense. Systemic immunetherapy has prolonged life for many patients, and in the

case of cancer of thepancreas, Dr. Wyba states that about one-third of cases

have been cured using Wobenzyme.The enzymes must not be stopped or the cancer

recurs. The dose may need to beas much as 30 pills three times daily. We think

it may be wise to include enzymesalong with other therapies in treating cancer.

 

Enzyme Therapy inInfections

 

The human body reacts to infections byincreasing the viscosity of the blood.

This slows the flow of blood andincreases the clotting tendency of the blood. At

times, the clottingtendency is so exaggerated in infections, malignancies and

other disease statesthat there is widespread occurrence of fibrin clots all over

the body(disseminated intravascular coagulation). In this state, all of the

blood’ssubstances that are needed to cause the blood to clot become

consumed,resulting in no ability to clot. This leads to widespread hemorrhagic

are atthe same time there is a multitude of clots. Systemic enzyme therapy stops

theclotting tendency of blood that occurs in infections by its action to

dissolvefibrin. There is an increased risk of heart attacks and strokes

immediatelyafter acute infections (Chlamydia, Cocksackie viruses, etc.) and in

personssuffering from gingivitis.

 

Viral and BacterialInfections

 

Many infectious problems that trouble humans come to lightwhen a dormant virus

becomes activated after residing harmlessly for manyyears. A good example of

this is herpes zoster skin infection developing inpatients who had recovered

from an old chicken pox viral infection (varicellazoster) many years previously.

Herpes viruses may lie dormant for many years,only to produce very painful

neuritis at a later date.. This may follow anacute illness or any event that

injures the immune system(chemotherapy).

 

When a virus contacts a human cell, the external coatingconnects to the cell,

and the virus becomes able to contact DNA. Thisconnection to DNA permits the

virus to reproduce in a rapid manner. Proteolyticenzymes consume the exterior

coating of a virus rendering the virus permanentlyinert. To recover from a viral

infection requires that enough enzymes be takento get ahead of the rapid viral

replication within cells, This may require 5-10capsules of Vitalzyme + three

times daily or more.

 

BiofilmProtection for Bacterial Infection Involving Prosthetic Substances

 

One of the problems plaguing medicine currently is infectionof prosthetic

substances placed in the body(prosthetic hips, knees, heartvalves. etc.) These

infected prosthetic parts often need to be replaced, astheir infection can not

be eliminated. Bacteria are able to create a biofilmthat prevents antibiotic

drugs from reaching and killing them. A similarproblem exists in heart valve

infections, where frequently an emergencyreplacement of an infected valve

leaflet becomes the only way to save thepatient’s life. The proteolytic enzyme

serrapeptasewas shown to enhance the killing activity of the antibiotic Ofloxin

in culturesand to prevent theformation of biofilms.[5] This prevention of

biofilmscould become very valuable in treating these problem infections.

 

Enzyme Therapyin Allergic Diseases

 

There is an inflammatory component to the asthmatic attack.Use of enzymes during

an acute episode should be effective therapy in manypersons. Decreasing the

volume of secretions and causing the secretions tobecome less viscous so they

could be easier to cough up is also beneficial.Maintaining a low dosage of

enzymes, 2-3 capsules daily, should also create anenvironment in which it would

be more difficult for a new attack of asthma toget started.

 

The allergenic pollens irritating the nose in allergicrhinitis(hay fever) cause

the production of considerable mucous secretions.Taking enzymes should decrease

the volume of these secretions and thusalleviate the symptoms. As in asthma,

taking 2-3 enzyme capsules daily couldprove valuable by making it more difficult

for hay fever symptoms to beinitiated.

 

Use of Enzymesin Painful Conditions

 

Proteolytic enzymes are able to block the release of painproducing amines from

tissues that have inflammation. This elimination of painbenefits many

conditions. The disability of migraine headaches can usually behelped by enzyme

therapy. Sinus headaches can be alleviated by enzymes, whichdecrease and liquefy

secretions that contribute to the pain. A group of 59patients with acute and

chronic sinusitis were assigned to receive either theenzyme bromelain or placebo

along with conventional therapy (antibiotics,decongestants, etc.) The group

getting bromelain seemed to improve because itdissolved fibrin leading to

improved absorption of edema fluid, thus enablinggreater penetration of immune

system components. Obviously, one of the morevaluable uses for enzymes is to

relieve the pain in arthritic conditions,bursitis, and synovitis.

 

Lung Diseaseand Enzyme Therapy

Pulmonary Fibrosis:In pulmonary fibrosis the thin, filmy, alveolar membrane,

which permits oxygento enter the bloodstream and enables carbon dioxide to pass

from the blood intothe lung air spaces , becomes progressively thickened by the

laying down offibrin deposits on the alveolar membrane. These thickened alveoli

do not permitnormal oxygen for carbon dioxide exchange in the lung. Shortness of

breath thenappears with exertion.

 

Many disease states can cause a chest x-ray appearanceidentical with that of

pulmonary fibrosis. These conditions include cancer,infections, inhaled

irritants(asbestosis, silicosis, beryllium, etc.),sarcoidosis, diseases of

connective tissue (lupus, rheumatoid arthritis,scleroderma), and adverse drug

reactions (more than 50 cancause fibrosis including 14 chemotherapy drugs,

sulfa, penicillin, furadantin,hydralazine, aprèsaline, gold, chlorpropamide,

allopurinol, hydrochlorthiazide,and dilantin). Standard therapy for pulmonary

fibrosis includescourses of cortisone and immunosuppressive drugs (Imuran etc.)

if cortisonefails to benefit.

 

Since pulmonary fibrosis has progressive scarring and aninflammatory reaction in

the alveoli, therapy with systemic enzymes that digestfibrotic tissue and block

the inflammatory reaction should be a safe rationalapproach. Vitalzym + is

helping patients with pulmonary fibrosis. Start with 3capsules three times daily

on an empty stomach and raise the dosage at regularintervals until improvement

is noted.

Sarcoidosis A disease of unknown cause,sarcoidosis is more common in

Afro-American than Caucasians. The disease causesnodules and scarring in the

involved organs, Sarcoidosis is often discovered bya routine chest xray

revealing shadows in an adult with no symptoms. The lungis the most common organ

involved with the disease but the eyes, skin, nervoussystem, bones, and joints

may also be involved.

 

Lung symptoms may include cough, shortness of breath andwheezing. When the lung

symptoms are advanced or the disease involves criticalstructures(eyes, nervous

system) cortisone therapy is usually effective. Oftenit is impossible to

discontinue cortisone, which may need to be maintained inlow dosage.

 

A promising therapy for sarcoidosis is systemic enzymes fora trial period of 2-3

months. The inflammatory granulomas and scartissue(fibrosis) in the lung, eyes,

bones, joints and skin might very well beterminated by this therapy which is

much safer than cortisone. Regular increasein enzyme dosage will reach levels

where resolution of fibrosis can occur.

 

Use of Enzymesin Arthritic Diseases

 

Enzymatic therapy can benefit all forms of arthritis byreducing inflammation,

alleviating pain, and stopping the circulation ofinflammation causing immune

complexes. For these reasons many arthritisproducts contain

enzymes(bromelain,papain, etc.) Wherever there is pain there isinflammation

which can be blocked by enzymes.

 

Systemic LupusErythematosus

 

A key feature of SLE is allergic reactions in body tissues(auto-immunity).

Circulating immune complexes are routine, and the sites wherethey deposit

determine the symptoms of this disease, (lining membranes overlyinglung, heart,

abdomen, joints, brain, skin, etc,) A trial of systemic enzymescould remove

these circulating immune complexes from the blood of the SLEpatient.

Several months of enzyme therapy might have a dramatically beneficial effect

onthe disease. High dosage initially is a good idea. For part two click below.

 

Click here for part ----- & gt; 2, 

http://www.newswithviews.com/Howenstine/james175.htm

 

 

Footnotes:

 

1,Mazzone A. et al Evaluation of serratia peptidase in acute or

chronicinflammation of otolaryngogo;y pathology: A multi-cetre,

double-blind,randomized trial versus placebo. J Int Med Res 1990, 379-88

2, Esch PM, et al Reduction ofpostoperative swelling objective measurement of

the upper ankle joint intreatment with serrapeptase ------- A prospective study

(German) FortschrMed. 1989; 107(4)67-8, 71-2

3, Kee WH et al The treatment of breastengorgement with serrapeptase (Danzen) a

randomized double blindcontrolled trial Singapore MJ 1989; 48-54

4, Panaguriya A., et al A preliminarytrial of serrapeptase in patients with

carpal tunnel syndrome. J AssocPhysician India;47(12):170-172

5, Selan L et al Protolutic Enzymes: A new treatment strategyfor prosthetic

infections? Antimicro Agents Chemother, 1993;37(12):2618-21

 

 

© 2009 Dr. Howenstine -

 

 

Dr. A. Howenstine is a board certified specialistin internal medicine.

TheSecond Edition of his book A Physicians Guide To Natural Health Products

ThatWork is available.

 

Dr. Howenstine can be reached by writing Dr. Howenstine C/O Remarsa USA SB

37, P.O. Box 25292, Miami, Fl. 33102-5292.

E-Mail: dr.jimhow@...